Keywords:
Urinary Tract / Bladder, MR, Diagnostic procedure, Contrast agent-intravenous
Authors:
S. Donaldson1, B. Carrington1, R. Cowan1, J. Lyons1, D. Buckley2, S. Bonington1; 1Manchester/UK, 2Leeds/UK
DOI:
10.1594/ecr2011/C-2308
References
[1] CRUK.
Bladder cancer - survival statistics for England and Wales.
Vol 2009: Statistical information team,
Cancer Research UK; 2009.
[2] MacVicar D.
Carcinoma of the bladder: Cambridge University Press; 2008.
[3] Brix G,
Kiessling F,
Lucht R,
et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series.
Magn Reson Med 2004;52:420-429.
[4] Chan TY,
Epstein JI.
Radiation or chemotherapy cystitis with "pseudocarcinomatous" features.
Am J Surg Pathol 2004;28:909-913.
[5] Wong-You-Cheong JJ,
Woodward PJ,
Manning MA,
et al. From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation.
Radiographics 2006;26:1847-1868.
[6] Padhani AR,
Yarnold J,
Regan J,
et al. Dynamic MRI of breast hardness following radiation treatment.
J Magn Reson Imaging 2003;17:427-434.
[7] Ivancevic MK,
Zimine I,
Montet X,
et al. Inflow effect correction in fast gradient-echo perfusion imaging.
Magn Reson Med 2003;50:885-891.